Maria L. Chantar-Martinez

Bizkaia Science And Technology Park
Derio, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 182 publications

The histidine crossroad: An integrative theory of the gut-liver-vascular axis in MASLD.

The histidine crossroad: An integrative theory of the gut-liver-vascular axis in MASLD.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 15, 2026

A distinct domain organization of cystathionine β-synthase underlies cysteine and H2S biosynthesis in Pseudomonas aeruginosa and Klebsiella pneumoniae.

A distinct domain organization of cystathionine β-synthase underlies cysteine and H2S biosynthesis in Pseudomonas aeruginosa and Klebsiella pneumoniae.

Journal: Communications biology

Published: January 22, 2026

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma.

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma.

Journal: Molecular oncology

Published: December 01, 2025

Resmetirom Ameliorates Fibrogenesis in Hepatic Stellate Cells via Thyroid Hormone Receptor Alpha-Fatty-Acid Amide Hydrolase 1 Signaling Pathway.

Resmetirom Ameliorates Fibrogenesis in Hepatic Stellate Cells via Thyroid Hormone Receptor Alpha-Fatty-Acid Amide Hydrolase 1 Signaling Pathway.

Journal: MedComm

Published: October 29, 2025

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Trefoil Factor-3 Is a Hypoxia-Triggered Pro-Tumorigenic Factor in Hepatoblastoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 27, 2025

Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapy.

Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapy.

Journal: Science advances

Published: October 22, 2025

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Journal: Molecular metabolism

Published: October 19, 2025

Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients.

Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: October 16, 2025

Disruption of Reelin signaling in a dual-hit mouse model of schizophrenia: impact of postnatal Δ9-tetrahydrocannabinol exposure in a maternal immune activation model.

Disruption of Reelin signaling in a dual-hit mouse model of schizophrenia: impact of postnatal Δ9-tetrahydrocannabinol exposure in a maternal immune activation model.

Journal: Translational psychiatry

Published: August 26, 2025

Minor players, major signals: Unveiling the systemic and gut-localized impact of microbial amidated bile acids in hepatopancreatobiliary disease.

Minor players, major signals: Unveiling the systemic and gut-localized impact of microbial amidated bile acids in hepatopancreatobiliary disease.

Journal: Hepatology (Baltimore, Md.)

Published: July 14, 2025

Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition.

Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition.

Journal: Acta pharmacologica Sinica

Published: July 10, 2025

Identification of Circulating MiR-4651 as Novel Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease.

Identification of Circulating MiR-4651 as Novel Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Gastro hep advances

Published: June 27, 2025

Showing 1-12 of 182

Last Updated: 09/26/2026